Do MTRR rs1801394 AG and TCN2 rs1801198 CG affect cellular B12 use and methionine synthase activity?

Cellular vitamin B12 utilization and methionine synthesis depend on highly coordinated transport and enzymatic reactivation pathways. Polymorphisms in the MTRR and TCN2 genes can disrupt these physiological processes.

Mechanistic pathways of B12 transport and MTR reactivation

• TCN2 rs1801198 CG (Pro259Arg): This heterozygous missense variant alters the secondary and tertiary structure of transcobalamin II. This modification results in intermediate levels of plasma holotranscobalamin (holo-TC)—the active B12 fraction that binds CD320 cell-surface receptors—leading to reduced cellular transport efficiency compared to the wild-type CC genotype.
• MTRR rs1801394 AG (Ile22Met): Located in the enzyme’s FMN-binding domain, this variant impairs physical binding and electron transfer between methionine synthase reductase (MTRR) and the methionine synthase (MTR)-cobalamin complex. Consequently, the rate of converting inactive cob(II)alamin back to active methylcob(III)alamin using S-adenosylmethionine (SAM) is moderately reduced.

Clinical and metabolic implications

• Functional intermediate states: Both the TCN2 CG and MTRR AG genotypes present intermediate, heterozygous phenotypes. While carriers often maintain normal systemic B12 levels, intracellular availability and MTR reactivation kinetics are subtly compromised.
• Compounding risk factors: In isolation, these genetic variations are typically compensated for by alternative metabolic pathways. However, when combined, or under conditions of low dietary intake, malabsorption, or concurrent folate pathway mutations, they significantly elevate the risk of functional B12 insufficiency, elevated methylmalonic acid, and hyperhomocysteinemia.

Bottom line

• The TCN2 rs1801198 CG and MTRR rs1801394 AG genotypes represent functional modifiers that moderately reduce cellular B12 delivery and slow down the reactivation of active methionine synthase, acting as key genetic risk factors for impaired methylation during nutritional or metabolic stress.